{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:33Z","timestamp":1789609113474,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cld.2022.08.011","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T04:34:53Z","timestamp":1666067693000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pruritus in Chronic Liver Disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Ranya","family":"Selim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2022.08.011_bib1","doi-asserted-by":"crossref","first-page":"295891","DOI":"10.1155\/2015\/295891","article-title":"Management of pruritus in chronic liver disease","volume":"2015","author":"Bhalerao","year":"2015","journal-title":"Dermatol Res Pract"},{"issue":"19","key":"10.1016\/j.cld.2022.08.011_bib2","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3748\/wjg.v23.i19.3418","article-title":"Recent advances in the management of pruritus in chronic liver diseases","volume":"23","author":"Tajiri","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2022.08.011_bib3","first-page":"9","article-title":"Prurit et virus de l'h\u00e9patite C. Le Groupe Multivirc [Pruritus and the hepatitis C virus. The MULTIVIRC Unit]","volume":"125","author":"Dega","year":"1998","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.cld.2022.08.011_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/liv.12026","article-title":"Sleep-Wake profiles in patients with primary biliary cirrhosis","volume":"33","author":"Montagnese","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2022.08.011_bib5","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1111\/hepr.12978","article-title":"Prevalence of pruritus in patients with chronic liver disease: a multicenter study","volume":"48","author":"Oeda","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2022.08.011_bib6","doi-asserted-by":"crossref","first-page":"639674","DOI":"10.3389\/fmed.2021.639674","article-title":"Cholestasis-associated pruritus and its pruritogens","volume":"8","author":"Langedijk","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.cld.2022.08.011_bib7","first-page":"117","article-title":"Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin","volume":"82","author":"Ghent","year":"1987","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2022.08.011_bib8","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1113\/JP273961","article-title":"Lysophosphatidic acid-induced itch is mediated by signalling of LPA","volume":"595","author":"Kittaka","year":"2017","journal-title":"J\u00a0Physiol"},{"issue":"3","key":"10.1016\/j.cld.2022.08.011_bib9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","article-title":"Lysophosphatidic acid is a potential mediator of cholestatic pruritus","volume":"139","author":"Kremer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2022.08.011_bib10","doi-asserted-by":"crossref","first-page":"30847","DOI":"10.1038\/srep30847","article-title":"Serum autotaxin is a Marker of the severity of liver injury and overall Survival in patients with cholestatic liver diseases","volume":"6","author":"Wunsch","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.cld.2022.08.011_bib11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.1840110526","article-title":"The pruritus of cholestasis: from bile acids to opiate agonists","volume":"11","author":"Jones","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.08.011_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.26909","article-title":"Pruritus in cholestasis: Facts and fiction","volume":"60","author":"Beuers","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.08.011_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.21759","article-title":"Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States","volume":"46","author":"Peters","year":"2007","journal-title":"Hepatology"},{"issue":"1\u20132","key":"10.1016\/j.cld.2022.08.011_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/13557859998173","article-title":"Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution","volume":"4","author":"Abedin","year":"1999","journal-title":"Ethn Health"},{"issue":"17","key":"10.1016\/j.cld.2022.08.011_bib15","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","article-title":"Clinical practice. Chronic pruritus","volume":"368","author":"Yosipovitch","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cld.2022.08.011_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11894-009-0079-2","article-title":"Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis","volume":"12","author":"Zein","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"10.1016\/j.cld.2022.08.011_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/hep.21987","article-title":"Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine","volume":"47","author":"Glantz","year":"2008","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.cld.2022.08.011_bib18","first-page":"773","article-title":"Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids","volume":"6","author":"di Padova","year":"1984","journal-title":"Methods Findings Exp Clin Pharmacol"},{"issue":"6436","key":"10.1016\/j.cld.2022.08.011_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.289.6436.22","article-title":"Treatment of pruritus due to chronic obstructive liver disease","volume":"288","author":"Duncan","year":"1984","journal-title":"Br Med J"},{"issue":"6A","key":"10.1016\/j.cld.2022.08.011_bib20","doi-asserted-by":"crossref","first-page":"47C","DOI":"10.1016\/j.amjcard.2006.11.022","article-title":"Safety considerations with gastrointestinally active lipid-lowering drugs","volume":"99","author":"Jacobson","year":"2007","journal-title":"Am J Cardiol"},{"issue":"supplement 1","key":"10.1016\/j.cld.2022.08.011_bib21","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0168-8278(03)00006-0","article-title":"Current management of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"38","author":"Levy","year":"2003","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2022.08.011_bib22","first-page":"533","article-title":"Rifampicin as treatment for pruritus in malignant cholestasis","volume":"6","author":"Price","year":"1998","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.cld.2022.08.011_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.50.3.436","article-title":"Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis","volume":"50","author":"Prince","year":"2002","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2022.08.011_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.cld.2022.08.011_bib25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaad.2009.08.052","article-title":"Antipruritic treatment with systemic \u03bc-opioid receptor antagonists: a review","volume":"63","author":"Phan","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.cld.2022.08.011_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2022.08.011_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4065\/81.3.330","article-title":"Anticipating potential linezolid-SSRI interactions in the general hospital setting: an MAOI in disguise","volume":"81","author":"Sola","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cld.2022.08.011_bib28","series-title":"The extant works of aretaeus, the cappadocian","author":"Adams","year":"1865"},{"key":"10.1016\/j.cld.2022.08.011_bib29","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/hep.30496","article-title":"Effect of plasmapheresis on cholestatic pruritus and autotaxin Activity during pregnancy","volume":"69","author":"Heerkens","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2022.08.011_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200634","article-title":"Refractory pruritus in primary biliary cirrhosis","volume":"2013","author":"Pinheiro","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.cld.2022.08.011_bib31","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/apt.13449","article-title":"The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European study","volume":"43","author":"Hegade","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.cld.2022.08.011_bib32","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1136\/gut.2008.175380","article-title":"Artificial and bioartificial liver devices: present and future","volume":"58","author":"Carpentier","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.cld.2022.08.011_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200634","article-title":"Refractory pruritus in primary biliary cirrhosis","volume":"2013","author":"Pinheiro","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.cld.2022.08.011_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2340\/00015555-1620","volume":"93","author":"St\u00e4nder","year":"2013","journal-title":"Acta Derm Venereol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326122000757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:59:45Z","timestamp":1761069585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326122000757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1089326122000757"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2022.08.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pruritus in Chronic Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2022.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}